Systemic complications of rheumatoid arthritis: Focus on pathogenesis and treatment
Open accessThe DOI matches its Crossref record; 142 of the 142 references it cites were found in a registry or an index.
Abstract
As a systemic autoimmune disease, rheumatoid arthritis (RA) usually causes damage not only to joints, but also to other tissues and organs including the heart, kidneys, lungs, digestive system, eyes, skin, and nervous system. Excessive complications are closely related to the prognosis of RA patients and even lead to increased mortality. This article summarizes the serious complications of RA, focusing on its incidence, pathogenesis, clinical features, and treatment methods, aiming to provide a reference for clinicians to better manage the complications of RA.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
RETRACTED: Rheumatoid arthritis (RA) and cardiovascular disease
Blum, A., & Adawi, M. (2019) · Autoimmunity Reviews · doi:10.1016/j.autrev.2019.05.005 · Cited by 87
RetractedThe Pathogenesis of Rheumatoid Arthritis
McInnes, I. B., & Schett, G. (2011) · New England Journal of Medicine · doi:10.1056/nejmra1004965 · Cited by 5,514 · cited 1×
“These factors all have a deleterious effect on bone (132).”
BackgroundScott, D. L., Wolfe, F., & Huizinga, T. W. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60826-4 · Cited by 3,013
Nintedanib in Progressive Fibrosing Interstitial Lung Diseases
Flaherty, K. R., Wells, A. U., Cottin, V., Devaraj, A., Walsh, S. L. F., Inoue, Y., Richeldi, L., Kolb, M., Tetzlaff, K., Stowasser, S., et al. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1908681 · Cited by 2,403
McGettigan, P., & Henry, D. (2006) · JAMA · doi:10.1001/jama.296.13.jrv60011 · Cited by 1,096
Update on the Pathomechanism, Diagnosis, and Treatment Options for Rheumatoid Arthritis
Lin, Y.-J., Anzaghe, M., & Schülke, S. (2020) · Cells · doi:10.3390/cells9040880 · Cited by 932
Restoring synovial homeostasis in rheumatoid arthritis by targeting fibroblast-like synoviocytes
Nygaard, G., & Firestein, G. S. (2020) · Nature Reviews Rheumatology · doi:10.1038/s41584-020-0413-5 · Cited by 928
Anti-Inflammatory Action and Mechanisms of Resveratrol
Meng, T., Xiao, D., Muhammed, A., Deng, J., Chen, L., & He, J. (2021) · Molecules · doi:10.3390/molecules26010229 · Cited by 698
Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications
England, B. R., Thiele, G. M., Anderson, D. R., & Mikuls, T. R. (2018) · BMJ · doi:10.1136/bmj.k1036 · Cited by 609
Overview of MMP-13 as a Promising Target for the Treatment of Osteoarthritis
Hu, Q., & Ecker, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22041742 · Cited by 475
Methotrexate mechanism in treatment of rheumatoid arthritis
Friedman, B., & Cronstein, B. (2019) · Joint Bone Spine · doi:10.1016/j.jbspin.2018.07.004 · Cited by 439
Beyond the joints, the extra-articular manifestations in rheumatoid arthritis
Conforti, A., Di Cola, I., Pavlych, V., Ruscitti, P., Berardicurti, O., Ursini, F., Giacomelli, R., & Cipriani, P. (2021) · Autoimmunity Reviews · doi:10.1016/j.autrev.2020.102735 · Cited by 407
Pulmonary rehabilitation for interstitial lung disease
Dowman, L., Hill, C. J., & Holland, A. E. (2014) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006322.pub3 · Cited by 381
Kadura, S., & Raghu, G. (2021) · European Respiratory Review · doi:10.1183/16000617.0011-2021 · Cited by 328
The role of autoantibodies in the pathophysiology of rheumatoid arthritis
Derksen, V. F. A. M., Huizinga, T. W. J., & van der Woude, D. (2017) · Seminars in Immunopathology · doi:10.1007/s00281-017-0627-z · Cited by 327
Sleep and rheumatologic disorders
Abad, V. C., Sarinas, P. S. A., & Guilleminault, C. (2008) · Sleep Medicine Reviews · doi:10.1016/j.smrv.2007.09.001 · Cited by 312
Pulmonary rehabilitation for interstitial lung disease
Dowman, L., Hill, C. J., May, A., & Holland, A. E. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd006322.pub4 · Cited by 309
EULAR points to consider for the management of difficult-to-treat rheumatoid arthritis
Nagy, G., Roodenrijs, N. M. T., Welsing, P. M. J., Kedves, M., Hamar, A., van der Goes, M. C., Kent, A., Bakkers, M., Pchelnikova, P., Blaas, E., et al. (2022) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2021-220973 · Cited by 287
Regulation of TNF-Induced Osteoclast Differentiation
Yao, Z., Getting, S. J., & Locke, I. C. (2021) · Cells · doi:10.3390/cells11010132 · Cited by 280 · cited 1×
“Inflammatory cytokines induce osteoclast maturation and inhibit osteoblast activation to perturb bone homeostasis, thus, anti-TNF therapy can improve bone homeostasis in RA patients (143, 144).”
BackgroundMyasoedova, E., Davis, J., Matteson, E. L., & Crowson, C. S. (2020) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2019-216694 · Cited by 253
Fonseca, L. J. S. D., Nunes-Souza, V., Goulart, M. O. F., & Rabelo, L. A. (2019) · Oxidative Medicine and Cellular Longevity · doi:10.1155/2019/7536805 · Cited by 248
Rheumatoid arthritis and citrullination
Darrah, E., & Andrade, F. (2018) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000452 · Cited by 236
Yokota, K., Sato, K., Miyazaki, T., Aizaki, Y., Tanaka, S., Sekikawa, M., Kozu, N., Kadono, Y., Oda, H., & Mimura, T. (2021) · Arthritis & Rheumatology · doi:10.1002/art.41666 · Cited by 225
Rempenault, C., Combe, B., Barnetche, T., Gaujoux-Viala, C., Lukas, C., Morel, J., & Hua, C. (2018) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2017-211836 · Cited by 220
Md Yusof, M. Y., Kabia, A., Darby, M., Lettieri, G., Beirne, P., Vital, E. M., Dass, S., & Emery, P. (2017) · Rheumatology · doi:10.1093/rheumatology/kex072 · Cited by 214
Molecular and Cellular Pathways Contributing to Joint Damage in Rheumatoid Arthritis
Fang, Q., Zhou, C., & Nandakumar, K. S. (2020) · Mediators of Inflammation · doi:10.1155/2020/3830212 · Cited by 208
Interleukin-1 blockade in cardiovascular diseases: a clinical update
Buckley, L. F., & Abbate, A. (2018) · European Heart Journal · doi:10.1093/eurheartj/ehy128 · Cited by 194
Regulation of Immune Responses and Chronic Inflammation by Fibroblast-Like Synoviocytes
Yoshitomi, H. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01395 · Cited by 194
Hydroxychloroquine in rheumatic autoimmune disorders and beyond
Nirk, E. L., Reggiori, F., & Mauthe, M. (2020) · EMBO Molecular Medicine · doi:10.15252/emmm.202012476 · Cited by 192
Secondary Osteoporosis and Metabolic Bone Diseases
Sobh, M., Abdalbary, M., Elnagar, S., Nagy, E., Elshabrawy, N. A., Abdelsalam, M., Asadipooya, K., & El-Husseini, A. A. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11092382 · Cited by 190
The Role of Reactive Oxygen Species in the Rheumatoid Arthritis-Associated Synovial Microenvironment
Wang, X., Fan, D., Cao, X., Ye, Q., Wang, Q., Zhang, M., & Xiao, C. (2022) · Antioxidants · doi:10.3390/antiox11061153 · Cited by 189
The British Society for Rheumatology biologic DMARD safety guidelines in inflammatory arthritis
Holroyd, C. R., Seth, R., Bukhari, M., Malaviya, A., Holmes, C., Curtis, E., Chan, C., Yusuf, M. A., Litwic, A., Smolen, S., et al. (2019) · Rheumatology · doi:10.1093/rheumatology/key208 · Cited by 183
Adipokines: Linking metabolic syndrome, the immune system, and arthritic diseases
Francisco, V., Ruiz-Fernández, C., Pino, J., Mera, A., González-Gay, M. A., Gómez, R., Lago, F., Mobasheri, A., & Gualillo, O. (2019) · Biochemical Pharmacology · doi:10.1016/j.bcp.2019.03.030 · Cited by 181
Favalli, E. G. (2020) · Rheumatology and Therapy · doi:10.1007/s40744-020-00219-2 · Cited by 178
Multi-Target Approaches in Metabolic Syndrome
Lillich, F. F., Imig, J. D., & Proschak, E. (2021) · Frontiers in Pharmacology · doi:10.3389/fphar.2020.554961 · Cited by 178
Juarez, M., Bang, H., Hammar, F., Reimer, U., Dyke, B., Sahbudin, I., Buckley, C. D., Fisher, B., Filer, A., & Raza, K. (2016) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2014-206785 · Cited by 175
Maeda, K., Yoshida, K., Nishizawa, T., Otani, K., Yamashita, Y., Okabe, H., Hadano, Y., Kayama, T., Kurosaka, D., & Saito, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23052871 · Cited by 161
Vitamin D Deficiency, Osteoporosis and Effect on Autoimmune Diseases and Hematopoiesis: A Review
Martinis, M. D., Allegra, A., Sirufo, M. M., Tonacci, A., Pioggia, G., Raggiunti, M., Ginaldi, L., & Gangemi, S. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168855 · Cited by 154
Pharmacotherapy and adjunctive treatment for idiopathic pulmonary fibrosis (IPF)
Saito, S., Alkhatib, A., Kolls, J. K., Kondoh, Y., & Lasky, J. A. (2019) · Journal of Thoracic Disease · doi:10.21037/jtd.2019.04.62 · Cited by 148
Shao, T., Shi, X., Yang, S., Zhang, W., Li, X., Shu, J., Alqalyoobi, S., Zeki, A. A., Leung, P. S. C., & Shuai, Z. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.684699 · Cited by 147
Takeuchi, T., Tanaka, Y., Soen, S., Yamanaka, H., Yoneda, T., Tanaka, S., Nitta, T., Okubo, N., Genant, H. K., & van der Heijde, D. M. F. M. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-214827 · Cited by 141
Manfredi, A., Cassone, G., Furini, F., Gremese, E., Venerito, V., Atzeni, F., Arrigoni, E., Casa, G. D., Cerri, S., Govoni, M., et al. (2019) · Internal Medicine Journal · doi:10.1111/imj.14670 · Cited by 141
Osteoporosis in Rheumatoid Arthritis: Dangerous Liaisons
Llorente, I., García-Castañeda, N., Valero, C., González-Álvaro, I., & Castañeda, S. (2020) · Frontiers in Medicine · doi:10.3389/fmed.2020.601618 · Cited by 139
Roles of Exosomes Derived From Immune Cells in Cardiovascular Diseases
Wu, R., Gao, W., Kang, Y., & Ge, J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00648 · Cited by 138
Resveratrol ameliorates rheumatoid arthritis via activation of SIRT1‐Nrf2 signaling pathway
Wang, G., Xie, X., Yuan, L., Qiu, J., Duan, W., Xu, B., & Chen, X. (2019) · BioFactors · doi:10.1002/biof.1599 · Cited by 130
Adam, S., Simon, N., Steffen, U., Andes, F. T., Scholtysek, C., Müller, D. I. H., Weidner, D., Andreev, D., Kleyer, A., Culemann, S., et al. (2020) · Science Translational Medicine · doi:10.1126/scitranslmed.aay4447 · Cited by 130
The Key Comorbidities in Patients with Rheumatoid Arthritis: A Narrative Review
Taylor, P. C., Atzeni, F., Balsa, A., Gossec, L., Müller‐Ladner, U., & Pope, J. E. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10030509 · Cited by 128
Autoimmunity and Inflammation Link to Cardiovascular Disease Risk in Rheumatoid Arthritis
DeMizio, D. J., & Geraldino-Pardilla, L. B. (2019) · Rheumatology and Therapy · doi:10.1007/s40744-019-00189-0 · Cited by 119
Sarıyıldız (2013) · Journal of Clinical Medicine Research · doi:10.4021/jocmr1648w · Cited by 117
Langdahl, B. L., Silverman, S. L., Fujiwara, S., Saag, K. G., Napoli, N., Soen, S., Enomoto, H., Melby, T. E., Disch, D. P., Marín, F., et al. (2018) · Bone · doi:10.1016/j.bone.2018.07.013 · Cited by 114
Kronzer, V. L., Huang, W., Dellaripa, P. F., Huang, S., Feathers, V. L., Lü, B., Iannaccone, C. K., Gill, R. R., Hatabu, H., Nishino, M., et al. (2020) · The Journal of Rheumatology · doi:10.3899/jrheum.200863 · Cited by 113
Cardiovascular Involvement in Autoimmune Diseases
Amaya‐Amaya, J., Montoya-Sánchez, L., & Rojas‐Villarraga, A. (2014) · BioMed Research International · doi:10.1155/2014/367359 · Cited by 110
How Autoantibodies Regulate Osteoclast Induced Bone Loss in Rheumatoid Arthritis
Steffen, U., Schett, G. A., & Bözec, A. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.01483 · Cited by 103
Neto, E. T. D. R., Kakehasi, A. M., Pinheiro, M. A. A., Ferreira, G. A., Marques, C. D. L., da Mota, L. M. H., Paiva, E. D. S., Pileggi, G. S., Sato, E. I., Gomides, A. P. M., et al. (2020) · Revista Brasileira de Reumatologia · doi:10.1186/s42358-020-00134-8 · Cited by 102
Janus kinase inhibitors: A therapeutic strategy for cancer and autoimmune diseases
Hosseini, A., Gharibi, T., Marofi, F., Javadian, M., Babaloo, Z., & Baradaran, B. (2020) · Journal of Cellular Physiology · doi:10.1002/jcp.29593 · Cited by 101
Raterman, H. G., & Lems, W. F. (2019) · Drugs & Aging · doi:10.1007/s40266-019-00714-4 · Cited by 100
Cardiovascular Disease Risk in Rheumatoid Arthritis Anno 2022
Dijkshoorn, B., Raadsen, R., & Nurmohamed, M. T. (2022) · Journal of Clinical Medicine · doi:10.3390/jcm11102704 · Cited by 99
Xia, Z., Meng, F., Fang, Y., Wu, X., Zhang, C.-W., Liu, Y., Liu, D., Li, G., Feng, F.-B., & Qiu, H.-Y. (2018) · Medicine · doi:10.1097/md.0000000000010920 · Cited by 98
Hanada, M., Kasawara, K. T., Mathur, S., Rozenberg, D., Kozu, R., Hassan, S. A., & Reid, W. D. (2020) · Journal of Thoracic Disease · doi:10.21037/jtd.2019.12.27 · Cited by 98
Management issues in rheumatoid arthritis-associated interstitial lung disease
England, B. R., & Hershberger, D. M. (2020) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000703 · Cited by 89
Kochumon, S., Madhoun, A. S. A., Al‐Rashed, F., Thomas, R., Sindhu, S. T. A. K., Al‐Ozairi, E., Al‐Mulla, F., & Ahmad, R. (2020) · Scientific Reports · doi:10.1038/s41598-020-73347-y · Cited by 87
Cardiac Dysfunction in Rheumatoid Arthritis: The Role of Inflammation
Chen, J., Norling, L. V., & Cooper, D. (2021) · Cells · doi:10.3390/cells10040881 · Cited by 86
Zamarrón, C., Maceiras, F., Mera, A., & Gómez-Reino, J. J. (2003) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2003.007831 · Cited by 85
Senescent T-Cells Promote Bone Loss in Rheumatoid Arthritis
Fessler, J., Husic, R., Theiler‐Schwetz, V., Lerchbaum, E., Aberer, F., Fasching, P., Ficjan, A., Obermayer-Pietsch, B. M., Duftner, C., Graninger, W. B., et al. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00095 · Cited by 84
Kerola, A. M., Rollefstad, S., & Semb, A. G. (2021) · European Cardiology Review · doi:10.15420/ecr.2020.44 · Cited by 84
Sleep Disturbances and Interleukin 6 Receptor Inhibition in Rheumatoid Arthritis
FRAGIADAKI, K., TEKTONIDOU, M. G., KONSTA, M., CHROUSOS, G. P., & SFIKAKIS, P. P. (2012) · The Journal of Rheumatology · doi:10.3899/jrheum.110617 · Cited by 82
New and emerging concepts in the use of denosumab for the treatment of osteoporosis
Lewiecki, E. M. (2018) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x18805759 · Cited by 82
Hu, X., Wu, Y., Zhang, J., & Wei, W. (2019) · International Immunopharmacology · doi:10.1016/j.intimp.2019.03.008 · Cited by 81
Adipokines and Autoimmunity in Inflammatory Arthritis
Neumann, E., Hasseli, R., Ohl, S., Lange, U., Frommer, K., & Müller‐Ladner, U. (2021) · Cells · doi:10.3390/cells10020216 · Cited by 80
Huang, S., Kronzer, V. L., Dellaripa, P. F., Deane, K. D., Bolster, M. B., Nagaraja, V., Khanna, D., Doyle, T. J., & Sparks, J. A. (2020) · Current Treatment Options in Rheumatology · doi:10.1007/s40674-020-00160-z · Cited by 79
Anticitrullinated protein antibodies facilitate migration of synovial tissue-derived fibroblasts
Sun, M. Y., Réthi, B., Krishnamurthy, A., Joshua, V., Cîrciumaru, A., Hensvold, A. H., Ossipova, E., Grönwall, C., Liu, Y., Engström, M., et al. (2019) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2018-214967 · Cited by 78
Interstitial Lung Disease in Rheumatoid Arthritis: A Practical Review
Laria, A., Lurati, A. M., Zizzo, G., Zaccara, E., Mazzocchi, D., Re, K. A., Marrazza, M., Faggioli, P. M., & Mazzone, A. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.837133 · Cited by 77
Giles, J. T. (2019) · Clinical Therapeutics · doi:10.1016/j.clinthera.2019.04.018 · Cited by 74
Khan, S. I., Andrews, K. L., & Chin-Dusting, J. P. F. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20174262 · Cited by 74
Ntusi, N., Francis, J. M., Sever, E., Liu, A., Piechnik, S. K., Ferreira, V. M., Matthews, P., Robson, M. D., Wordsworth, P. B., Neubauer, S., et al. (2018) · International Journal of Cardiology · doi:10.1016/j.ijcard.2018.06.099 · Cited by 73
Rubio-Ruiz, M. E., Guarner‐Lans, V., Cano-Martínez, A., Díaz‐Díaz, E., Manzano-Pech, L., Gamas-Magaña, A., Castrejón-Téllez, V., Tapia-Cortina, C., & Pérez-Torres, I. (2019) · Molecules · doi:10.3390/molecules24071297 · Cited by 72
AMPK is associated with the beneficial effects of antidiabetic agents on cardiovascular diseases
Lu, Q., Li, X., Liu, J., Sun, X., Rousselle, T., Ren, D., Tong, N., & Li, J. (2019) · Bioscience Reports · doi:10.1042/bsr20181995 · Cited by 69 · cited 1×
“Metformin, Phenformin (64) Affects AMPK activity,Downregulate the level of inflammation, Improving lipid metabolism”
BackgroundRheumatoid arthritis and risk of cardiovascular disease
Meyer, P. W. A., Anderson, R., Ker, J. A., & Ally, M. M. T. M. (2018) · Cardiovascular journal of South Africa/Cardiovascular journal of Southern Africa · doi:10.5830/cvja-2018-018 · Cited by 69
Bone Metabolism and RANKL/OPG Ratio in Rheumatoid Arthritis Women Treated with TNF-α Inhibitors
Jura-Półtorak, A., Szeremeta, A., Olczyk, K., Zoń‐Giebel, A., & Komosińska‐Vassev, K. (2021) · Journal of Clinical Medicine · doi:10.3390/jcm10132905 · Cited by 69
Guo, G., Fu, T., Yin, R., Zhang, L., Zhang, Q., Xia, Y., Li, L., & Gu, Z. (2016) · Health and Quality of Life Outcomes · doi:10.1186/s12955-016-0550-3 · Cited by 67
Bako, H. Y., Ibrahim, M. A., Isah, M. S., & Ibrahim, S. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.117045 · Cited by 67
Savola, P., Brück, O. E., Olson, T. L., Kelkka, T., Kauppi, M. J., Kovanen, P. E., Kytölä, S. I., Sokka‐Isler, T., Loughran, T. P., Leirisalo‐Repo, M., et al. (2017) · Haematologica · doi:10.3324/haematol.2017.175729 · Cited by 64
JAK/STAT pathway and molecular mechanism in bone remodeling
Sanpaolo, E. R., Rotondo, C., Cici, D., Corrado, A., & Cantatore, F. P. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05910-9 · Cited by 64
Ebner, L., Christodoulidis, S., Stathopoulou, T., Geiser, T., Stalder, O., Limacher, A., Heverhagen, J. T., Mougiakakou, S. G., & Christe, A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0226084 · Cited by 62
Yang, J. A., Lee, J. S., Park, J. K., et al. (2017) · The Korean Journal of Internal Medicine · doi:10.3904/kjim.2016.349 · Cited by 60
Jamthikar, A. D., Gupta, D., Puvvula, A., Johri, A. M., Khanna, N. N., Saba, L., Mavrogeni, S. I., Laird, J. R., Pareek, G., Miner, M. M., et al. (2020) · Rheumatology International · doi:10.1007/s00296-020-04691-5 · Cited by 58
Endothelial Dysfunction and Extra-Articular Neurological Manifestations in Rheumatoid Arthritis
Maiuolo, J., Muscoli, C., Gliozzi, M., Musolino, V., Carresi, C., Scicchitano, M., Bosco, F., Macrì, R., Scarano, F., Ruga, S., et al. (2021) · Biomolecules · doi:10.3390/biom11010081 · Cited by 55
Cai, W., Tang, X., & Pang, M. (2022) · Frontiers in Medicine · doi:10.3389/fmed.2022.855141 · Cited by 55
Immunosuppressive treatment and the risk of diabetes in rheumatoid arthritis
Lillegraven, S., Greenberg, J. D., Reed, G. W., Saunders, K., Curtis, J. R., Harrold, L., Hochberg, M. C., Pappas, D. A., Kremer, J. M., & Solomon, D. H. (2019) · PLOS ONE · doi:10.1371/journal.pone.0210459 · Cited by 54
Ischemic Heart Disease and Rheumatoid Arthritis—Two Conditions, the Same Background
Rezuş, E., Macovei, L. A., Burlui, A., Cardoneanu, A., & Rezuș, C. (2021) · Life · doi:10.3390/life11101042 · Cited by 54
Austad, C., Kvien, T. K., Olsen, I. C., & Uhlig, T. (2016) · Scandinavian Journal of Rheumatology · doi:10.3109/03009742.2016.1168482 · Cited by 53
Wells, G., Li, T., & Tugwell, P. (2010) · Annals of the Rheumatic Diseases · doi:10.1136/ard.2009.119727 · Cited by 51
Self-citationBSR and BHPR guidelines on the use of rituximab in rheumatoid arthritis
Bukhari, M. A. S., Abernethy, R., Deighton, C., Ding, T., Hyrich, K. L., Lunt, M., Luqmani, R. A., Kiely, P. D. W., Bosworth, A., Ledingham, J. M., et al. (2011) · Lara D. Veeken · doi:10.1093/rheumatology/ker106a · Cited by 51
Complement and its environmental determinants in the progression of human rheumatoid arthritis
Bemis, E. A., Norris, J. M., Seifert, J. A., Frazer‐Abel, A. A., Okamoto, Y., Feser, M. L., Demoruelle, M. K., Deane, K. D., Banda, N. K., & Holers, V. M. (2019) · Molecular Immunology · doi:10.1016/j.molimm.2019.05.012 · Cited by 51
Johnson, T. M., Sayles, H. R., Baker, J. F., George, M., Roul, P., Zheng, C., Sauer, B. C., Liao, K. P., Anderson, D. R., Mikuls, T. R., et al. (2021) · Annals of the Rheumatic Diseases · doi:10.1136/annrheumdis-2021-220125 · Cited by 51
T Cells in Autoimmunity-Associated Cardiovascular Diseases
Muallem, D. R., Burma, A. M., Kitakule, M. M., Luo, Y., & Mehta, N. N. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.588776 · Cited by 50
Self-citationPathogenesis of ischaemic and non-ischaemic heart diseases in rheumatoid arthritis
Błyszczuk, P., & Szekanecz, Z. (2020) · RMD Open · doi:10.1136/rmdopen-2019-001032 · Cited by 49
Metformin, an AMPK Activator, Inhibits Activation of FLSs but Promotes HAPLN1 Secretion
Chen, Y., Fujuan, Q., Yu, B., Chen, Y., Zuo, F., Zhu, X., Nandakumar, K. S., & Xiao, C. (2020) · Molecular Therapy — Methods & Clinical Development · doi:10.1016/j.omtm.2020.05.008 · Cited by 48
Yu, K.-H., Chen, H.-H., Cheng, T.-T., Jan, Y.-J., Weng, M.-Y., Lin, Y.-J., Chen, H.-A., Cheng, J.-T., Huang, K.-Y., Li, K.-J., et al. (2022) · Medicine · doi:10.1097/md.0000000000028501 · Cited by 47
Tardella, M., Carlo, M. D., Carotti, M., Giovagnoni, A., & Salaffi, F. (2021) · Clinical Rheumatology · doi:10.1007/s10067-021-05854-w · Cited by 46
Comorbidities As Risk Factors for Rheumatoid Arthritis and Their Accrual After Diagnosis
Kronzer, V. L., Crowson, C. S., Sparks, J. A., et al. (2019) · Mayo Clinic Proceedings · doi:10.1016/j.mayocp.2019.08.010 · Cited by 43
Verma, A. K., Bhatt, D., Goyal, Y., Dev, K., Beg, M. M. A., Alsahli, M. A., & Rahmani, A. H. (2021) · Journal of Multidisciplinary Healthcare · doi:10.2147/jmdh.s285469 · Cited by 43
Køster, D., Egedal, J. H., Lomholt, S., Hvid, M., Jakobsen, M. R., Müller‐Ladner, U., Eibel, H., Deleuran, B. W., Kragstrup, T. W., Neumann, E., et al. (2021) · Scientific Reports · doi:10.1038/s41598-021-01692-7 · Cited by 42
Ferreira, M. B., Fonseca, T., Costa, R. Q., Marinhoc, A., Carvalho, H. C., Oliveira, J. C., Zannad, F. M., Rossignol, P., Gottenberg, J., Saraiva, F. A., et al. (2020) · European Journal of Internal Medicine · doi:10.1016/j.ejim.2020.11.002 · Cited by 40
Arrhythmias and Conduction Disturbances in Autoimmune Rheumatic Disorders
Plastiras, S. C., & Moutsopoulos, H. Μ. (2021) · Arrhythmia & Electrophysiology Review · doi:10.15420/aer.2020.43 · Cited by 40
Jönsson, E., Ljung, L., Norrman, E., Freyhult, E., Ärlestig, L., Dahlqvist, J., & Rantapää‐Dahlqvist, S. (2021) · Rheumatology · doi:10.1093/rheumatology/keab441 · Cited by 40
Cook, A. D., & Hamilton, J. A. (2018) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x17752036 · Cited by 37
Agca, R., Blanken, A. B., van Sijl, A. M., Smulders, Y. M., Voskuyl, A. E., van der Laken, C. J., Boellaard, R., & Nurmohamed, M. T. (2020) · Lara D. Veeken · doi:10.1093/rheumatology/keaa789 · Cited by 35
Patel, R. B., & Shah, S. J. (2018) · The Annual Review of Pharmacology and Toxicology · doi:10.1146/annurev-pharmtox-010818-021136 · Cited by 34
Liang, M., Matteson, E. L., Abril, A., & Distler, J. H. W. (2022) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x221074457 · Cited by 34
Atienza‐Mateo, B., Remuzgo‐Martínez, S., Prieto-Pena, D., Cuesta, V. M. M., Fernandez, D. I., Llorca, J., Sánchez-Bilbao, L., Corrales, A., Rodríguez, G. B., Gómez‐Román, J., et al. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9103070 · Cited by 33
Ebina, K., Hirao, M., Hashimoto, J., Hagihara, K., Kashii, M., Kitaguchi, K., Matsuoka, H., Iwahashi, T., Chijimatsu, R., & Yoshikawa, H. (2017) · Journal of Bone and Mineral Metabolism · doi:10.1007/s00774-017-0861-4 · Cited by 32
Osteoporosis in patients with rheumatoid arthritis: trends in the German National Database 2007–2017
Lindner, L., Callhoff, J., Alten, R., Krause, A., Ochs, W., Zink, A., & Albrecht, K. (2020) · Rheumatology International · doi:10.1007/s00296-020-04593-6 · Cited by 32
George, M., Baker, J. F., & Ogdie, A. (2019) · The Journal of Rheumatology · doi:10.3899/jrheum.190299 · Cited by 31
Huang, S., Yoon, S., Shimizu, K., Chng, W. J., Chang, C., Wong, R. S. M., Gao, S., Wang, Y., Gordon, S. W., Glennane, A., et al. (2020) · Advances in Therapy · doi:10.1007/s12325-020-01395-x · Cited by 31
Vascular cell adhesion molecule-1 in rheumatoid arthritis patients
Salem, H. R., & Zahran, E. S. (2021) · Saudi Medical Journal · doi:10.15537/smj.2021.42.6.20200753 · Cited by 29
Effect of statin use on the risk of rheumatoid arthritis: A systematic review and meta-analysis
Myasoedova, E., Karmacharya, P., Duarte‐García, A., Davis, J. M., Murad, M. H., & Crowson, C. S. (2020) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2020.03.008 · Cited by 28
Wang, C., & Tsai, H. (2021) · World Journal of Diabetes · doi:10.4239/wjd.v12.i3.238 · Cited by 28
Vacchi, C., Manfredi, A., Cassone, G., Erre, G. L., Salvarani, C., & Sebastiani, M. (2021) · Drugs in Context · doi:10.7573/dic.2020-8-7 · Cited by 27
The role of interleukin-6 trans-signalling on cardiovascular dysfunction in inflammatory arthritis
Davies, R., Williams, J. O., Sime, K., Jin, H.-S., Thompson, C., Jordan, L. A., Lang, D., Halcox, J., Ellins, E. A., Jones, G. W., et al. (2020) · Rheumatology · doi:10.1093/rheumatology/keaa725 · Cited by 25
Yang, X., Wei, D., Liu, M., Wu, B., Zhang, J., Xu, H., Ye, S., Liu, F., Hu, C., & Chen, J. (2021) · Clinical Rheumatology · doi:10.1007/s10067-021-05704-9 · Cited by 25
Bhattacharya, P. K., Barman, B., Jamil, M., & Bora, K. (2020) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2020-0015 · Cited by 24
Sex and Cardiovascular Involvement in Inflammatory Joint Diseases
Castañeda, S., González‐Juanatey, C., & González-Gay, M. Á. (2017) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-017-8635-2 · Cited by 23
Virone, A., Bastard, J., Fellahi, S., Capeau, J., Rouanet, S., Sibilia, J., Ravaud, P., Berenbaum, F., Gottenberg, J., & Sellam, J. (2019) · RMD Open · doi:10.1136/rmdopen-2019-000897 · Cited by 22
Guin, A., Sinhamahapatra, P., Misra, S., Mazumder, S. R., Chatterjee, S., & Ghosh, A. (2019) · Biomedical Journal · doi:10.1016/j.bj.2019.01.007 · Cited by 22
Wang, N., Zhang, Q., Jing, X., Guo, J., Huang, H. F., & Xu, Z. (2020) · Medical Science Monitor · doi:10.12659/msm.920137 · Cited by 22
Lo, C.-H., Wei, J. C., Wang, Y., Tsai, C., Chan, K., Li, L.-C., Lo, T.-H., & Su, C.-H. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.631869 · Cited by 22
Clinical profile and outcome of patients with chronic inflammatory arthritis and metabolic syndrome
Cioffi, G., Viapiana, O., Tarantini, L., Orsolini, G., Idolazzi, L., Ognibeni, F., Dalbeni, A., Gatti, D., Fassio, A., Rossini, M., et al. (2020) · Internal and Emergency Medicine · doi:10.1007/s11739-020-02520-y · Cited by 21
Rheumatoid Arthritis and Associated Lung Diseases: A Comprehensive Review
Azam, A. T., Odeyinka, O., Alhashimi, R., Thoota, S., Ashok, T., Palyam, V., & Sange, I. (2022) · Cureus · doi:10.7759/cureus.22367 · Cited by 21
de Jong, H. J. I., Tervaert, J. W. C., Lalmohamed, A., de Vries, F., Vandebriel, R. J., Loveren, H. V., Klungel, O. H., & van Staa, T. P. (2018) · PLoS ONE · doi:10.1371/journal.pone.0193297 · Cited by 20
Proarrhythmic electrophysiological and structural remodeling in rheumatoid arthritis
Patel, K. H. K., Jones, T., Sattler, S., Mason, J. C., & Ng, F. S. (2020) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00401.2020 · Cited by 20
Chen, M., Yu, S., Chen, J., Chen, W., Liou, T.-L., Chou, C., Hsu, C., Lai, H., Chen, Y., Tsai, C., et al. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.783030 · Cited by 19
Tektonidou, M. G., Katsifis, G. E., Georgountzos, A. I., Theodoridou, A., Koukli, E.-M., Kandili, A., Giokic-Kakavouli, G., & Karatsourakis, T.-D. (2020) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x20949088 · Cited by 17
Arija, S. M., Vázquez, N. M., Garnica, I. U., Rioja, J., Valdivielso, P., Ginel-Mendoza, L., Abad-Sánchez, S., Jiménez-Núñez, F. G., Oliver‐Martos, B., & Fernández‐Nebro, A. (2021) · BMJ Open · doi:10.1136/bmjopen-2020-044749 · Cited by 17
Cardiac eccentric remodeling in patients with rheumatoid arthritis
Pascale, V., Finelli, R., Giannotti, R., Coscioni, E., Izzo, R., Rozza, F., Caputo, D., Moscato, P., Iaccarino, G., & Ciccarelli, M. (2018) · Scientific Reports · doi:10.1038/s41598-018-24323-0 · Cited by 15
Cohen, S. B., Greenberg, J. D., Harnett, J., Madsen, A. M., Smith, T. W., Gruben, D. C., Zhang, R. H., Lukić, T., Woolcott, J. C., Dandreo, K. J., et al. (2020) · Advances in Therapy · doi:10.1007/s12325-020-01501-z · Cited by 14
Cavalli, G., & Favalli, E. G. (2018) · Annals of Translational Medicine · doi:10.21037/atm.2018.10.72 · Cited by 9
Acute effect of oxygen therapy on exercise tolerance and dyspnea perception in ILD patients
Ora, J., Coppola, A., Perduno, A., Manzetti, G. M., Puxeddu, E., & Rogliani, P. (2021) · Monaldi Archives for Chest Disease · doi:10.4081/monaldi.2021.1925 · Cited by 9
Turgunova, L., Shalygina, A. A., Zalkalns, J., Klyuyev, D. A., Akhmaltdinova, L., & Досмагамбетова, Р. С. (2021) · Clinical Medicine Insights Arthritis and Musculoskeletal Disorders · doi:10.1177/1179544120985860 · Cited by 5
Azuaga-Piñango, A. B., & Peris, P. (2020) · Medicina Clínica · doi:10.1016/j.medcli.2019.12.005 · Cited by 3
Effect of antiresorptive and bone forming treatments in bone erosions in rheumatoid arthritis
Azuaga-Piñango, A. B., & Peris, P. (2020) · Medicina Clínica (English Edition) · doi:10.1016/j.medcle.2019.12.001 · Cited by 2
Infective Endocarditis-Like Presentation of Felty Syndrome: A Case Report
Hoshina, Y., Teaupa, S., & Chang, D. (2021) · Cureus · doi:10.7759/cureus.20713 · Cited by 1
Metadata
- Authors
- Wu, D., Luo, Y., Li, T., Zhao, X., Lv, T., Fang, G., Ou, P., Li, H., Luo, X., Huang, A., & Pang, Y.
- Venue
- Frontiers in Immunology
- Publisher
- Frontiers Media SA
- Published
- 2022-12-22
- Volume
- 13
- Pages
- 1051082-1051082
- ISSN
- 1664-3224 (ISSN-L)
- OpenAlex
- W4312076917
- Cited by
- 263
- References
- 142
- FWCI
- 28.64
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.